Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

11-1-2011

Type i collagen cleavage is essential for effective fibrotic repair
after myocardial infarction
Zengxuan Nong
Robarts Research Institute

Caroline O'Neil
Robarts Research Institute

Ming Lei
Western University

Robert Gros
Robarts Research Institute

Alanna Watson
Robarts Research Institute

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Nong, Zengxuan; O'Neil, Caroline; Lei, Ming; Gros, Robert; Watson, Alanna; Rizkalla, Amin; Mequanint,
Kibret; Li, Shaohua; Frontini, Matthew J.; Feng, Qingping; and Pickering, J. Geoffrey, "Type i collagen
cleavage is essential for effective fibrotic repair after myocardial infarction" (2011). Paediatrics
Publications. 1237.
https://ir.lib.uwo.ca/paedpub/1237

Authors
Zengxuan Nong, Caroline O'Neil, Ming Lei, Robert Gros, Alanna Watson, Amin Rizkalla, Kibret Mequanint,
Shaohua Li, Matthew J. Frontini, Qingping Feng, and J. Geoffrey Pickering

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/1237

The American Journal of Pathology, Vol. 179, No. 5, November 2011
Copyright © 2011 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
DOI: 10.1016/j.ajpath.2011.07.017
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Type I Collagen Cleavage Is Essential for Effective
Fibrotic Repair after Myocardial Infarction

Zengxuan Nong,* Caroline O’Neil,* Ming Lei,†
Robert Gros,*† Alanna Watson,*‡ Amin Rizkalla,§
Kibret Mequanint,§ Shaohua Li,*
Matthew J. Frontini,* Qingping Feng,† and
J. Geoffrey Pickering*‡¶储
From the Robarts Research Institute * and the Departments of
Physiology and Pharmacology,† Biochemistry,‡ Chemical and
Biochemical Engineering,§ Medicine (Cardiology),¶ and Medical
Biophysics,储 University of Western Ontario, London, Ontario,
Canada

Efficient deposition of type I collagen is fundamental to
healing after myocardial infarction. Whether there is
also a role for cleavage of type I collagen in infarct
healing is unknown. To test this, we undertook coronary artery occlusion in mice with a targeted mutation
(Col1a1r/r) that yields collagenase-resistant type I collagen. Eleven days after infarction, Col1a1r/r mice had a
lower mean arterial pressure and peak left ventricular
systolic pressure, reduced ventricular systolic function,
and worse diastolic function, compared with wild-type
littermates. Infarcted Col1a1r/r mice also had greater
30-day mortality, larger left ventricular lumens, and
thinner infarct walls. Interestingly, the collagen fibril
content within infarcts of mutant mice was not increased. However, circular polarization microscopy revealed impaired collagen fibril organization and mechanical testing indicated a predisposition to scar
microdisruption. Three-dimensional lattices of collagenase-resistant fibrils underwent cell-mediated contraction, but the fibrils did not organize into birefringent
collagen bundles. In addition, time-lapse microscopy revealed that, although cells migrated smoothly on wild-type
collagen fibrils, crawling and repositioning on collagenase-resistant collagen was impaired. We conclude that
type I collagen cleavage is required for efficient healing of
myocardial infarcts and is critical for both dynamic positioning of collagen-producing cells and hierarchical assembly of collagen fibrils. This seemingly paradoxical requirement for collagen cleavage in fibrotic repair should
be considered when designing potential strategies to inhibit matrix degradation in cardiac disease. (Am J Pathol
2011, 179:2189 –2198; DOI: 10.1016/j.ajpath.2011.07.017)

Rapid deposition of type I collagen is critical to cardiac
repair after myocardial infarction. When effectively elaborated, a type I collagen-rich matrix provides a mechanically strong network that maintains cardiac integrity, minimizes infarct expansion, and resists maladaptive
remodeling.1 Elaboration of type I collagen is a multistep
process that includes expression of the genes encoding
pro-␣1(I) and pro-␣2(I) collagen chains, intracellular
winding of the chains, and secretion of type I procollagen. Outside the cell, the propeptide termini are cleaved
and the resulting triple helical type I collagen assembles
into fibrils, which then cross-link and pack.2
Collagen deposition can be opposed by processes that
degrade type I collagen. Enzymes that destroy the integrity
of type I collagen by cleaving the triple helical domain are
important in this regard. These include the interstitial collagenases, matrix metalloproteinase (MMP)⫺1, MMP-8, and
MMP-13, that cleave type I collagen three fourths along the
length of its triple helix. Broader-spectrum MMPs, such as
MMP-2 and membrane-type (MT)1-MMP/MMP-14, also
have the capacity to cleave native type I collagen.3,4 Several studies have highlighted the potential for interstitial collagenases to adversely affect the heart. Transgenic expression of MMP-1 promotes ventricular dilatation and
dysfunction,5 and serum levels of MMP-1 have been associated with poor patient outcomes after infarction.6 The
expression of MMP-8 has been associated with postinfarct ventricular rupture as well,7 and MMP-13 is substantially up-regulated in the failing heart.8 There is
also strong evidence linking activation of broaderspectrum MMPs with adverse ventricular remodeling
after infarction.9
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Despite these findings, proof that type I collagen cleavage adversely affects healing after a myocardial infarction is
lacking. Moreover, although it seems intuitive that degrading type I collagen is not desired during fibrotic myocardial
repair, it is also possible that proteolytic collagen editing is
important (eg, to ensure that the developing scar can productively remodel in the face of changing hemodynamic
stresses). Determining whether there is a beneficial role for
collagen degradation is particularly important, given that
inhibiting extracellular matrix degradation is proposed as a
potential therapy for myocardial infarction.9
To elucidate the role of collagenase-mediated type I
collagen degradation in the healing response to myocardial infarction, we examined the consequences of coronary artery occlusion in mice expressing a collagenaseresistant form of type I collagen. These mice express a
modified ␣1(I) collagen chain that prevents the seminal
three-fourths to one-fourth cleavage event within the type I
collagen triple helix.10,11 We specifically investigated
whether the scarring process was affected, using birefringence imaging, microtensile testing, and time-lapse
assessment of the cell-collagen fibril interplay in vitro. We
report that the ability of type I collagen to be cleaved in its
triple helical domain is critical for effective fibrotic repair
after myocardial infarction in mice.

Materials and Methods
Transgenic Mice
Heterozygous mice containing a targeted mutation of the
col1a1 gene (B6,129-Col1a1tm1Jae) were obtained from
Jackson Laboratory, Bar Harbor, ME. These mice contain
targeted substitutions of three amino acids at the threefourths to one-fourth collagenase cleavage site of the
␣1(I) collagen chain, rendering the triple helical domain
of type I collagen resistant to proteolytic cleavage.11 Homozygous (Col1a1r/r) offspring and wild-type littermates,
on the hybrid B6,129 background, were used for this
study. Mice were genotyped by PCR analysis of genomic
DNA harvested from the tail.12

Myocardial Infarction
Experiments were performed in accordance with protocols approved by the Animal Care and Use Committee of
the University of Western Ontario, London, Ontario, Canada. Myocardial infarctions were generated in 12- to 16week-old male mice by permanent occlusion of the left
anterior descending (LAD) coronary artery under general
anesthesia [ketamine (80 mg/kg) and xylazine (10 mg/
kg)], as described.13 As a control, sham– operated on
mice were subjected to surgical anesthesia and their
chests were opened, but they did not receive coronary
artery ligation. Outcome analyses were undertaken by
investigators (Z.N., M.L.) blinded to treatment groups and
mouse genotype.

Hemodynamic Assessment
The arterial blood pressure and heart rate were recorded
from anesthetized mice after cannulating the right carotid
artery with a Millar-tip transducer catheter (model SPR-261,
1.4F; Millar Instruments, Inc., Houston TX). The catheter was
subsequently advanced into the left ventricle (LV) for measurement of peak LV systolic pressure, LV end-diastolic
pressure, maximal rate of systolic pressure development,
and maximal rate of diastolic pressure decline.

Tissue Harvesting and Histological Analyses
Eleven days after surgery, mice were anesthetized and
hearts were arrested in diastole by infusion of 1 mL of 0.1
mol/L KCl into the inferior vena cava. Hearts were then
subjected to retrograde perfusion through the aorta with
PBS at a pressure of 100 mmHg, followed by 3 minutes of
pressurized perfusion with 4% paraformaldehyde. Excised hearts were immersion fixed in 4% paraformaldehyde for an additional 24 hours and transversely bisected
at the level of the coronary ligation. The distal region was
embedded in paraffin and cross-sectioned from the ligation site to the apex, obtaining 15 serial sections (5-m
thick) every 500 m. Sections were stained with Picrosirius red by incubating deparaffinized sections with
0.1% Sirius red F3BA in saturated picric acid for 30
minutes and rinsing twice with 0.01 mol/L HCl. Cardiac
morphometry was assessed in digitally imaged sections
(Northern Eclipse, Empix Imaging, Inc., Mississauga, ON,
Canada). The infarct size was determined as the endocardial circumference of the infarct zone, in absolute terms and
relative to that of the total left ventricular chamber, averaged
from all sections obtained. The thickness of the infarct zone
was determined by dividing the infarct area measurement
by the midline infarct circumference from all sections. The
left ventricular chamber area was based on the endocardial
circumference, and the largest area served as the index of
chamber size.14 The fraction of collagen in the infarct zone
was quantified as the area of red staining tissue/total infarct
wall area, in three low-power (⫻10 objective) fields per
section. Myofibroblast alignment was evaluated in the border regions of the infarct. The relative alignment of myofibroblasts was assessed from the long axis of approximately
100 nuclei within the fibrotic region zone (Northern Eclipse).
The diversity of alignment was determined based on the SD
of the angle distributions.

Tensile Testing
Microtensile stress tests were conducted using a computer-controlled Instron machine (model 3345; Instron
Corporation, Canton, MA) at a cross-head speed of 0.5
mm/minute and using a 10N load cell. A circumferential
strip of infarct zone (width, approximately 2 mm) was
freshly excised from hearts 11 days after LAD coronary
artery occlusion. The specimen was attached to a flat
grip using Vetbond (3M Animal Care Products, St. Paul,
MN), and the exact cross-sectional area of each specimen was determined using a micrometer. Specimens
were positioned parallel to the axis of the grip to reduce
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bending stresses. The modulus of elasticity of each specimen was calculated from the slope of the elastic portion
of the stress-strain curves.

Cell Culture
Cardiac fibroblasts were isolated from the myocardium of
C57BL/6 mice.15 Briefly, minced ventricles were subjected to six 10-minute incubations in Hanks’ buffer containing type II collagenase (100 U/mL) at 37°C. Released
cells were pelleted, resuspended in Dulbecco’s modified
Eagle’s medium with 10% fetal bovine serum, and plated.
After 3 hours, unattached cells were removed, adherent
fibroblasts were grown for 6 to 7 days until confluence,
and fibroblasts at passage two or three were studied.
Human vascular smooth muscle cells (SMCs) were cultured by outgrowth from the internal thoracic artery, as
previously described.16,17

Collagen Isolation and Analysis of 3D Lattices
Tails of wild-type or Col1a1r/r mice were dissolved in 0.1
mol/L acetic acid and collagen purified, as previously
described.18 The collagen concentration was determined
spectrophotometrically (absorbance, 540 nm) from Picrosirius red–stained aliquots dried onto microtiter wells.
Three-dimensional (3D) collagen lattices were generated
by adding a suspension of 6 ⫻ 105 cells/mL to an equal
volume of neutralized collagen solution (2 mg/mL). The mixture, 1 mL, was then added to wells of a 24-well dish and
allowed to polymerize at 37°C for 1 hour, before adding 1
mL of Dulbecco’s modified Eagle’s medium with 10% fetal
bovine serum. To initiate cell-mediated contraction of the
lattice, gels were released from the well edges. Expression
of smooth muscle ␣-actin was assessed by immunostaining
using a mouse monoclonal antibody (clone 1A4; DAKO
Canada Inc., Burlington, ON, Canada), and the presence of
collagenase-cleaved type I collagen was assessed by using a rabbit polyclonal antibody (C1-2C; IBEX Pharmaceuticals, Inc., Mount-Royal, QC, Canada).

Collagen Birefringence Imaging
Collagen organization was assessed using circular polarization microscopy.19 Picrosirius red–stained sections
of myocardium and 3D collagen lattices were visualized
using a Nikon Optiphot-Pol microscope (Nikon, Mississauga, ON, Canada) customized for circular polarization
optics20 or an Olympus BX51 microscope (Olympus Canada, Inc., Richmond Hill, ON, Canada) with polarizerinterference filters, a liquid crystal compensator, a
charge-coupled device video camera, and commercial
software (Abrio LC-PolScope; Cambridge Research and
Instrumentation, Inc., Hopkinton, MA). The latter system
enabled measurement of light retardation by collagen, in
absolute terms (nanometers), in defined fields of view. In
3D collagen lattices, 6 to 10 randomly selected cells per
condition that had their long axis parallel to the section
plane were studied. The mean collagen retardation was
quantified in two regions of interest defined by the nuclear area, on either side of the nucleus, and corrected

for the mean retardation of collagen fibrils in regions
between the cells. As an additional approach that
avoided cell selection, total collagen birefringence was
assessed in five full fields of view (objective, ⫻60) to yield
the sum of retardation signals (in nanometers) for all
pixels in the images. This summed value was corrected
for collagen retardation in regions devoid of cells by
subtracting the corresponding summed signal normalized for area. The cumulative retardation value was then
divided by the total number of cells in the fields of view.

Migration Analysis
Myofibroblast and SMC motility was evaluated using digital time-lapse video microscopy.21–23 Cells plated onto
dishes coated with a polymerized 3D network of mouse
tail collagen (0.8 mg/mL) were imaged with an inverted
microscope (Zeiss Axiovert S100; Cornwall, ON, Canada
or Leica DMI6000 B; Concord, ON, Canada) using modulated contrast optics. Images were digitally acquired
every 5 minutes during a 6- to 8-hour recording period,
using a high-resolution charge-coupled device camera
(Sony XC-75/75CE; EMPIX Imaging, Inc. or Leica
DFC420 C video camera; Leica Microsystems Canada,
Inc.) and time-lapse software (Northern Eclipse, Empix
Imaging, Inc., and Leica Application Suite; Leica Microsystems Canada Inc.). The ambient temperature was
maintained at 37°C using a temperature control cell [CC100 (20/20 Technology, Inc., Wilmington, NC) and LiveCell (Pathology Devices, Westminster, MD)]. To maintain
physiological pH in room air, cells were incubated in
bicarbonate-reduced medium M199 with Hanks’ salts
and 25 mmol/L HEPES.

Statistics
Data are expressed as mean ⫾ SEM. Comparisons between groups were made with the Student’s t-test. Survival was evaluated with Kaplan-Meier analysis, and
comparisons between groups were made by log-rank
and Wilcoxon testing. Frequencies of mechanical microdisruption were compared using the Fisher’s exact test.

Results
Survival after Myocardial Infarction Is Reduced
in Mice Expressing a Collagenase-Resistant
Form of Type I Collagen
The effect of collagenase-resistant type I collagen on survival after myocardial infarction was assessed in 12- to
16-week-old Col1a1r/r mice and wild-type littermates. Fortysix male mice, 23 Col1a1r/r mice, and 23 wild-type littermates were subjected to permanent LAD occlusion, and
survival was tracked over 1 month. One wild-type and one
mutant mouse died within 24 hours of surgery. An analysis
of the remaining 44 mice revealed that survival of mutant
mice was significantly worse than that of control mice (62%
versus 20% 30-day mortality; P ⬍ 0.05; Figure 1). Two
Col1a1r/r and two control mice displayed left ventricular
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tractile performance was 34.4% lower (P ⬍ 0.05), and left
ventricular diastolic performance was 31.2% lower (P ⬍
0.05). Thus, the inability to cleave type I collagen at the
three-fourths to one-fourth site adversely affected both
systolic and diastolic left ventricular performance after
myocardial infarction.

Ventricular Distortion after Myocardial Infarction
Is Worsened in Mice Producing CollagenaseResistant Type I Collagen

Figure 1. Survival of Col1a1r/r mice and wild-type littermates after myocardial infarction. Kaplan-Meier survival curves of male Col1a11r/r mice and
male wild-type littermates over 30 days after induction of myocardial infarction by permanent LAD occlusion. P ⫽ 0.03, Wilcoxon log-lank comparison.

rupture at death. There were no deaths in mice subjected to
sham surgery. These findings suggest that the elaboration
of collagenase-resistant type I collagen was not protective;
instead, it reduced post-infarct survival.

Cardiac Performance after Myocardial Infarction
Is Reduced in Mice Producing CollagenaseResistant Type I Collagen
To determine whether the increased death after infarction
among Col1a1r/r mice was associated with worsened cardiac performance, another 34 mice were subjected to
LAD occlusion and hemodynamics were evaluated after
11 days, using a Millar-tip transducer catheter. Among
sham– operated on mice, there were no differences in
heart rate, mean arterial pressure, peak left ventricular
systolic pressure, left ventricular contractile performance,
and left ventricular diastolic performance between
Col1a1r/r mice (n ⫽ 8) and wild-type littermates (n ⫽ 6)
(Table 1). However, among mice subjected to LAD occlusion, the mean arterial pressure of Col1a1r/r mice (n ⫽
9) was 34.9% lower than that of wild-type mice (n ⫽ 11)
(P ⬍ 0.01). Left ventricular systolic pressure in Col1a1r/r
mice was 23.5% lower (P ⬍ 0.05), left ventricular con-

Table 1.

Cardiac morphometry was assessed in Picrosirius red–
stained sections of hearts arrested in diastole and pressure
fixed 11 days after infarction or sham surgery. No differences in left ventricular chamber size or wall thickness were
found between Col1a1r/r and control mice subjected to a
sham operation (Figure 2). After LAD occlusion, the infarct
territory in wild-type mice occupied 36% ⫾ 1.7% of the
midventricular myocardium, and this was not different in
mutant mice (34% ⫾ 2.7%, P ⫽ 0.49). However, the infarct
zone was significantly thinner, attenuated by 26.8% (P ⬍
0.01, Figure 2) and the absolute length of the infarct zone
was greater in mutant than in wild-type mice (6.8 ⫾ 0.3
versus 5.2 ⫾ 0.4 mm; P ⬍ 0.01). Also, the left ventricular
chamber size was greater (48.7%, P ⬍ 0.01).
These morphometric data raised the possibility that the
healing infarct in Col1a1r/r mouse hearts was predisposed
to expansion. To further assess this, fresh segments of scar
zone 11 days after infarction were excised from the infarct
territory and subjected to tensile testing, using a 10N load
cell. The modulus of elasticity was 2.6 ⫾ 0.7 MPa in scar
segments from wild-type hearts (n ⫽ 4) and 1.5 ⫾ 0.4 MPa
in scars from Col1a1r/r hearts (n ⫽ 5, P ⫽ 0.22), suggesting
greater elasticity of mutant scars. The presence of abrupt,
but transient, losses of stretch-induced tension in the scars
from mutant hearts, well before total mechanical failure was
reached (Figure 3), was more striking, suggesting microdisruptions in the tissue as it was stretching. This phenomenon was observed in all five mutant infarcts studied (1.2
microfailures per scar) but only in one of four wild-type
infarcts (0.25 microfailures per scar, P ⬍ 0.05). These findings indicate that the infarct zone of mice expressing collagenase-resistant type I collagen has a reduced ability to
resist tensile forces.

Hemodynamic Parameters in WT and Col1a1r/r Mice after Myocardial Infarction
Sham–operated on mice
Parameter

WT (n ⫽ 6)

Heart rate (beats/minute)
MAP (mmHg)
LVSP (mmHg)
LVEDP (mmHg)
LV dP/dtmax (mmHg/second)
LV ⫺dP/dtmax (mmHg/second)

393 ⫾ 8
87 ⫾ 3
109 ⫾ 4
4.2 ⫾ 0.6
7973 ⫾ 484
8171 ⫾ 533

Col1a1

r/r

(n ⫽ 8)

392 ⫾ 9
87 ⫾ 6
112 ⫾ 5
3.7 ⫾ 0.4
7689 ⫾ 353
8404 ⫾ 400

LAD-occluded mice
WT (n ⫽ 11)

Col1a1r/r (n ⫽ 9)

420 ⫾ 13
86 ⫾ 5
106 ⫾ 8
11.6 ⫾ 2.1†
6916 ⫾ 453
6159 ⫾ 290†

391 ⫾ 9
56 ⫾ 4*
81 ⫾ 4*
7.9 ⫾ 0.7†
4607 ⫾ 441*
4239 ⫾ 380*

Values are given as mean ⫾ SEM.
*P ⬍ 0.05 vs sham and WT LAD occluded.
†
P ⬍ 0.05 vs sham.
dP/dtmax, maximum rate of increase in left ventricular systolic pressure; ⫺dP/dtmax, maximum rate of decline in left ventricular diastolic pressure; LVEDP,
left ventricular end-diastolic pressure; LVSP, peak left ventricular systolic pressure; MAP, mean artery pressure; WT, wild type.
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Figure 2. Impaired left ventricular remodeling after myocardial infarction (MI) in Col1a1r/r mice. A: Picrosirius red–stained cross sections of pressure-fixed hearts
arrested in diastole 11 days after sham surgery or LAD occlusion. B: There was a greater LV chamber area and a thinner infarct territory in Col1a1r/r mice after
MI compared with wild-type (WT) mice. No differences existed in sham– operated on hearts. *P ⬍ 0.05. C: Stress-strain plots of the scar zone harvested 11 days
after LAD occlusion in a WT (left) or a Col1a1r/r mutant (right) mouse. The plot for the mutant scar reveals greater elasticity and a small abrupt decline in the
generated stress in the otherwise linear portion of the curve (arrow), indicating a microdisruption event.

Healing Infarct Zone of Col1a1r/r Mice Displays
Abnormal Collagen Fibril Organization

collagen content within the infarct zone was also not
different between wild-type and mutant mice (50.8% ⫾
5.8% versus 54.2% ⫾ 4.4%), indicating that resistance to
collagen cleavage did not lead to an accumulation in
collagen fibers. In contrast, distinctions in collagen fibril
morphological features were noted. This was examined
using circularly polarized light, an approach that clearly

We next evaluated the fibrotic response in the hearts.
Collagen content in hearts subjected to sham surgery
was not different between wild-type and mutant mice
(4.6% ⫾ 0.04% versus 4.9% ⫾ 0.5%). Interestingly, the

A
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Figure 3. Collagen fibers in the infarct zone of
Col1a1r/r mice display less order. A: Circular
polarization microscopy images of Picrosirius
red–stained sections of the LV, 11 days after LAD
occlusion. Co-aligned bundles of birefringent
collagen fibers are seen in the infarct zone of
wild-type (WT) mice (left), whereas in Col1a1r/r
mice, fibers were more diffusely oriented and
thinner (middle). Insets (right): Well-delineated wavy appearance of collagen fibers (arrow) in the infarct zone of WT mice only (top
panel, arrow) versus those in mutant mice
(bottom panel). B: Digitally acquired retardation images of the infarct border zone of mice
after LAD occlusion, imaged with polarized light
and liquid crystal compensation. The resulting
retardation images (left) are independent of illumination intensity, such that images can be
directly compared. The corresponding heat
maps (right) depict reduced retardation in the
infarct zone of mutant mice, despite copious
collagen fibers having been deposited. Quantitative data from 11 mutant and 9 WT littermate
mice are shown. *P ⬍ 0.05.
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Collagenase-Resistant Collagen Fails to
Assemble into High-Ordered Fibrils in Response
to Cell-Mediated Contractile Forces
To determine whether the reduced collagen organization
was directly related to collagenase resistance, we evaluated the interplay between mesenchymal cells and collagen fibrils in a 3D network.25 Collagen fibril lattices
were prepared from collagen harvested from tails of wildtype or Col1a1r/r mice and embedded with mouse myocardial fibroblasts. Networks embedded with human vascular SMCs were similarly prepared, in view of the
myofibroblast-like attributes of these cells. When collagen fibril lattices are released from the sides of the culture dish, they contract, in association with elaboration of
collagen-degrading enzymes.26 We observed that both
mouse and human mesenchymal cells contracted the
collagen gels and that contraction did not occur if cells
were not present in the network. Interestingly, networks
generated from collagenase-resistant collagen contracted more than those constructed of wild-type collagen (63% ⫾ 4% versus 46% ⫾ 3% at 48 hours; P ⬍ 0.05;
Figure 3). Immunostaining using an antibody specific for
collagenase-cleaved type I collagen revealed a signal in
fibrils immediately adjacent to a few cells (⬍10%), suggesting highly localized collagen editing with a transient
cleavage product (Figure 4). Signal was not detected in
gels of mutant collagen. The proportion of fibroblasts in
mutant collagen that expressed immunodetectable
smooth muscle ␣-actin was not different from that for
fibroblasts in wild-type collagen (33.2% ⫾ 2.5% versus
33.8% ⫾ 2.2%), suggesting no differences in the intrinsic
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delineates fibril morphological features by innate collagen birefringence enhanced by the Picrosirius red stain.
Collagen fibrils in the infarct zone of mice expressing
wild-type type I collagen appeared as well-aligned, circumferentially oriented bands of thick fibers with a wavy
sinusoidal pattern (Figure 3A). In contrast, in the infarct
zone of Col1a1r/r mice, collagen fibers were thinner and
less organized. Moreover, these fibers typically did not
display sinusoidal periodicity (Figure 3A). These differences were particularly evident in the middle circumferential one third of the scar and the infarct borders.
Collagen birefringence increases as its molecular, supramolecular, and fibrillar orders increase, structural
changes that increase optical anisotropy.19,20,24 Therefore, we quantified collagen retardation as an indicator of
collagen organization within the fibrotic tissue. Retardation of collagen fibers in noninfarcted hearts was not
different between wild-type and mutant mice (4.9 ⫾ 0.7
versus 4.4 ⫾ 0.7 nm; P ⫽ 0.55). However, in mice subjected to infarction, the mean collagen retardation within
fibrotic regions was 18.0% lower in hearts of Col1a1r/r
compared with wild-type mice (Figure 3B). Together,
these morphological and birefringence findings indicate
that the inability to efficiently cleave type I collagen did
not affect collagen accumulation after infarction but significantly impaired the ability of elaborated collagen to
hierarchically organize.

12500
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Figure 4. Cell-mediated contraction of collagen fibril lattice and assembly of
pericellular collagen fibrils in vitro. A: The magnitude of contraction of
collagen lattices embedded with mouse cardiac fibroblasts and constructed
of either collagenase-resistant collagen or wild-type (WT) fibrils. B: Sections
from cell-embedded collagen fibril lattices stained after 48 hours with Picrosirius red and viewed with circular polarized light. Birefringent collagen
fibrils assembled on the surface of cell body and projections in the WT
collagen network (arrows). In contrast, only a modest accumulation of
birefringent fibrils can be seen around the cells in the network of collagenase-resistant collagen. Immunostaining at 24 hours using the C1-2C antibody revealed evidence for collagenase-cleaved type I collagen in immediate
pericellular regions in WT (arrows, top right panel), but not mutant
(bottom right panel), gels. C: Collagen fibril retardation of circularly polarized light. Retardation was quantified as the average retardation in defined
regions of interest associated with selected cells (left) and the average
cell-associated collagen retardation from the entire unselected field of view,
and expressed as summed retardation (right). *P ⬍ 0.05.

contractile properties of the cells. Collectively, these data
suggest a degree of collagen fibril disruption and/or slippage during the contraction process that did not proceed
in gels of mutant collagen.
To evaluate the architecture of the fibrils, lattices were
examined histologically and fibril retardation was quantified by polarization microscopy. Before contraction, both
wild-type and mutant fibrils appeared as relatively homogeneous lattices of fibrils (thickness, ⬍0.2 m). However,
after 48 hours of contraction, the collagen fibrils in the
immediate vicinity of the cells had substantially remodeled into thicker (1 to 8 m) and highly birefringent bundles of fibrils (Figure 4). This fibril reorganization was
observed for wild-type collagen but markedly less so for
collagenase-resistant collagen (Figure 4B). The mean retardation of pericellular collagen fibrils was 29.0% higher
in gels of wild-type collagen, when evaluated on fibrils
surrounding randomly selected individual cells, and
47.7% higher when assessed as the cumulative retardation index, normalized for background and the number of
cells in the section (Figure 4C). Taken together, these
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findings establish that, in response to cell-mediated contractile forces, collagen fibrils organize into high-ordered
bundles and that this assembly process requires the
proteolytic cleavage of the type I collagen triple helix.

Cell Migration and Positional Alignment Are
Inhibited by Collagenase-Resistant Collagen
Fibrils
The ability of collagen-producing cells to crawl into the
wound and appropriately orient also determines the efficacy of fibrotic healing. To determine whether collagenase-resistant collagen affected fibroblast/myofibroblast
positioning after infarction, we quantified the alignment of
mesenchymal cells in the infarct border zones, the site of
fibroblast/myofibroblast streaming. This revealed a
61.5% (P ⬍ 0.01) greater dispersion in fibroblast orientation in the hearts of Col1a1r/r mice compared with that in
infarcted hearts of wild-type mice (Figure 5A). This dispersed alignment suggests a reduced ability of the infiltrating mesenchymal cells to co-align in an environment
of collagenase-resistant collagen.
To further evaluate motility in a collagen fibril environment, we undertook time-lapse video microscopy of cells

on crawling along 3D lattices of wild-type or mutant type
I collagen. Mouse myocardial fibroblasts migrated along
a network of wild-type collagen, with a migration speed at
32.9 ⫾ 4.5 m/hour, and human SMCs migrated at
19.4 ⫾ 3.3 m/hour. However, the migration speeds of
either mouse or human cells were significantly lower
when they crawled on collagenase-resistant collagen fibrils (P ⬍ 0.01, Figure 5B).
Tracking the migration paths of individual cells revealed striking differences in the patterns of migration. As
illustrated in Figure 5, C and D, fibroblasts on wild-type
collagen typically translocated in a given direction for one
or more cell lengths and then turned and migrated in
another direction. This pattern reflects the lack of an
external chemotactic gradient but also indicates an ability of the cells to quickly reorient as they explore their
environment. In contrast, cells on collagenase-resistant
collagen displayed only minor shifts in the position of the
cell centroid and little change in the overall direction of
crawling. Moreover, although cells on wild-type collagen
glided smoothly over the fibrils, on mutant collagen they
exhibited a halting translocation pattern. This was associated with stretching and, at times, bending of the trailing aspect of the cell, which appeared to effectively with-

Figure 5. Cell motility and dynamic repositioning are suppressed on collagenase-resistant collagen. A: The SD of alignment of fibroblasts/myofibroblasts within
the transition zone of infarcted myocardium 11 days after LAD occlusion in control and Col1a1r/r mice. B: The migration speed of mouse myocardial fibroblasts
(light gray) and human SMCs (dark gray) crawling on a 3D collagen fibril lattice derived from the tails of either wild-type (WT) or Col1a1r/r mice. C: Spider plots
of mouse fibroblasts crawling on the designated collagen lattices. Tracings depict the hourly translocation of the cell centroid over 6 hours. D: Images of individual
cells crawling on collagen fibrils over 150 minutes. Arrows (top panel): A cell that translocates in a given direction and then turns to reorient approximately 90
degrees from its original path. Arrows (bottom panel): A cell in which the leading edge protrudes forward but the rear aspect does not release from the substrate,
resulting in stretching of the cell body and tail. The long arrow denotes the development of a bend in the stretched tail, suggesting additional restriction to cell
turning or reorientation. These distinctions in the dynamic motility patterns of cells on WT and mutant collagen can be seen in Supplemental Videos S1 and S2
(available at http://aip.ampathol.org). *P ⬍ 0.05 versus the corresponding WT value.
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hold the cell from changing position and orientation
(Figure 5D; see also Supplemental Video S1 at http://
aip.ampathol.org). The mutant collagen network itself was
seen to fold and compress underneath the cells, indicating that the cells were generating contractile forces necessary for migration but were incapable of releasing from
the collagen substrate to effectively translocate (see Supplemental Video S2 at http://aip.ampathol.org). These
findings reveal a collagen cleavage– based cellular release phenomenon that is necessary for collagen-producing cells to efficiently translocate and reorient in their
environment.

Discussion
We have studied the role of type I collagen cleavage in
the healing process after myocardial infarction in mice.
The findings reveal that mice that produce a collagenaseresistant form of type I collagen undergo maladaptive
ventricular remodeling after myocardial infarction, with
suppressed cardiac performance and increased mortality compared with littermate control mice. These adverse
events were associated with impaired hierarchical ordering of the collagen fibrils deposited in the infarct zone.
We also established that mesenchymal cells that were
otherwise fully capable of assembling collagen fibrils into
coherent bundles could not execute this function effectively with collagenase-resistant collagen fibrils. Moreover, the ability of mesenchymal cells to crawl, orient,
and co-align during tissue remodeling was impaired in
an environment of collagenase-resistant collagen.
These findings suggest that, despite the potential to
weaken a developing scar, proteolysis of type I collagen is required for key steps in fibrotic healing after
myocardial infarction.
Col1a1r/r mice contain a targeted mutation in the Col1a1
gene that eliminates the Gly775-Ile776 cleavage site located approximately three fourths along the length of the
triple helical domain of type I collagen. This is an important
proteolysis site because, once cleaved, the collagen triple
helix unfolds, rendering the collagen chains susceptible
to further proteolytic degradation. Several enzymes are
capable of mediating this cleavage, and several, including MMP-8, MMP-13, and MMP-14, are expressed after
myocardial infarction.8,27,28 Thus, Col1a1r/r mice constitute a powerful tool for elucidating the role of collagen
degradation during infarct healing, and their use circumvents compensation or redundancy among collagen-degrading enzymes. In addition, collagenases can have
targets other than type I collagen.9 Therefore, the findings observed with Col1a1r/r mice reflect only the altered
type I collagen and not enzymatic cleavage states of
other protein targets. Furthermore, because type I collagen in Col1a1r/r mice can still be cleaved at a secondary
N-telopeptide site,11 the current findings specifically establish the importance of three-fourths to one-fourth triple
helix cleavage in infarct repair.
Previous studies have established that Col1a1r/r mice
have a propensity to accumulate excess collagen fibers.
Aged Col1a1r/r mice accumulate collagen fibers in the

skin,11 and increased fibrosis has been found in atherosclerotic lesions29 and aneurysmal arteries.30 Given
these findings, it is noteworthy that collagen accumulation in the LV of Col1a1r/r mice after infarction was not
greater than that in control mice. This finding is consistent
with a previous report31 and probably reflects the fact
that the balance of production and degradation of type I
collagen after acute myocardial injury is heavily weighted
to the production side. However, the current findings also
establish that, despite this production bias, collagen degradation plays a key role in the infarct healing process.
This role was evidently not to control the amount of collagen deposited but to regulate the architecture of the
deposited fibrils. Qualitatively, wavy collagen fibers typical of well-organized fibrous tissue emerged in the infarct zone of control mice but generally not in the fibrotic
territory of Col1a1r/r mice. Quantitatively, fibrils in the
hearts of Col1a1r/r mice were less birefringent and had a
reduced ability to retard circularly polarized light. Thus,
the hierarchical collagen ordering process fundamental
to fibrotic healing requires three-fourths to one-fourth collagen cleavage.
The poor response to myocardial infarction in Col1a1r/r
mice could reflect a primary defect in collagen organization in the infarct zone or a secondary effect of a generalized perturbation in cardiovascular function in Col1a1r/r
mice. Although the latter possibility cannot be excluded,
we did not identify baseline cardiovascular abnormalities
in the Col1a1r/r mice studied. Heart rate, mean arterial
pressure, peak left ventricular systolic pressure, left ventricular chamber size, and left ventricular wall thickness
were similar in sham– operated on wild-type and mutant
mice. Thus, for example, baseline differences in afterload
are an unlikely explanation for the worsened response of
Col1a1r/r mice to infarction. Pre-infarction collagen fibril
content and organization were also not different between
mutant and wild-type mice.
Therefore, we propose that the maladaptive post-infarct remodeling in Col1a1r/r mice was because of the
elaboration of mutant collagen in the infarct zone, resulting in impaired fibrotic healing. This was supported by
mechanical testing, which identified a predisposition of
the scar zone in mutant mice to tension-induced microfailure. Moreover, in vitro analyses identified a direct relationship between the ability of collagen to undergo
cleavage and collagen fibril assembly. There may also be
modifier genes in the B6,129 strain used that heightened
the impact of the collagen mutation in vivo. Mice with a
129 background have been found to have more vulnerable infarct healing than inbred C57BL/6 mice32 and
greater activation of the renin-angiotensin system.33
Our 3D culture analyses identified two components of
tissue remodeling that depend on collagenase-competent collagen fibrils. The first component is the phenomenon of cell contraction-mediated assembly of collagen
fibrils. We identified that collagen fibril assembly proceeds at the cell surface and found that this fiber-building
process required collagen fibrils that can be cleaved at
the three-fourths to one-fourth proteolysis site. The fact
that collagen fibril birefringence decreased when collagen cleavage was abrogated seems paradoxical but

Collagen Cleavage and Myocardial Infarct
2197
AJP November 2011, Vol. 179, No. 5

suggests a process by which site-specific collagen
cleavage enables collagen fibrils to reassemble into
thicker fibrils. The fact that contraction of mutant collagen
gels was greater than that of wild-type gels further suggests that this augmented fibril assembly process is
based on a highly functional collagen slippage phenomenon. Therefore, we propose that type I collagen fibrils
productively organize through a cleave-slide-and-reassemble cascade and that this cascade is critical to optimizing fibrosis after myocardial infarction.
The second process for which collagen fibril cleavage
was determined to be critical was optimizing the motility
and positioning of the collagen-producing cell. We found
that a 3D network of type I collagen fibrils was a suitable
substrate for motility and enabled a smooth, gliding migration pattern with efficient shifting of cell orientation.
However, on collagenase-resistant collagen, cell migration was slow and halting, with marked stretching of the
trailing aspect of the cell. Moreover, there was accentuated deformation and compression of the surrounding
collagen network. These findings suggest a role for collagen cleavage in loosening cell-substrate connections
to allow the cell body and tail to efficiently and appropriately follow the leading edge. Previous studies22,34 have
suggested that products of type I collagen cleavage may
be promigratory. Collagen cleavage might also be important for ensuring that other promigratory matrix molecules, such as minor collagens or fibronectin, can appropriately interact with the cell. Collagen synthesis is
suppressed in cells on or in a 3D lattice18,35; thus, in this
system, the dominant target for editing is likely pre-existing collagen fibrils. In vivo, cleavage of recently deposited
collagen may also be relevant, particularly because collagen deposition and maturation during wound healing
can proceed over days to weeks.20,36
The ability of fibroblasts to quickly reorient and finetune their direction of traveling within remodeling tissue
could serve two purposes. First, it could ensure that the
cell can explore and test its new environment efficiently.
Second, there may be a need for cells to rapidly shift
position in response to ongoing structural changes and
mechanical forces, a circumstance highly relevant to the
remodeling infarct zone.36 We found that in hearts expressing collagenase-resistant collagen there was reduced alignment of myofibroblasts entering the infarct
zone. Because fibroblast/myofibroblast alignment defines collagen fibril alignment, this impaired ability to reorient could be an additional means by which the fidelity
of scar formation was reduced.
In summary, despite the potential deleterious consequences of degrading collagen fibrils, cleavage of type I
collagen is required for effective fibrotic healing after
myocardial infarction in mice. Both the hierarchical assembly of collagen fibrils and the positioning of the collagen-elaborating cells depend on the capacity with
which type I collagen can be cleaved. The seemingly
paradoxical requirement of type I collagen cleavage for
cardiac repair should be considered when designing
therapeutic strategies to block matrix degradation in the
heart.

References
1. Jugdutt BI: Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 2003, 108:
1395–1403
2. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA: The biosynthesis
of collagen and its disorders. N Engl J Med 1979, 301:13–23, 77– 85
3. Aimes RT, Quigley JP: Matrix metalloproteinase-2 is an interstitial
collagenase: inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific
3/4- and 1/4-length fragments. J Biol Chem 1995, 270:5872–5876
4. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y: Membrane type
1 matrix metalloproteinase digests interstitial collagens and other
extracellular matrix macromolecules. J Biol Chem 1997, 272:2446 –
2451
5. Kim HE, Dalal SS, Young E, Legato MJ, Weisfeldt ML, D’Armiento J:
Disruption of the myocardial extracellular matrix leads to cardiac
dysfunction. J Clin Invest 2000, 106:857– 866
6. Soejima H, Ogawa H, Sakamoto T, Miyamoto S, Kajiwara I, Kojima S,
Hokamaki J, Sugiyama S, Yoshimura M, Suefuji H, Miyao Y, Fujimoto
K, Miyagi H, Kishikawa H: Increased serum matrix metalloproteinase-1 concentration predicts advanced left ventricular remodeling in
patients with acute myocardial infarction. Circ J 2003, 67:301–304
7. van den Borne SW, Cleutjens JP, Hanemaaijer R, Creemers EE, Smits
JF, Daemen MJ, Blankesteijn WM: Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial
infarction. Cardiovasc Pathol 2009, 18:37– 43
8. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T,
Goldberg AT, Zellner JL, Crumbley AJ: A matrix metalloproteinase
induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000, 102:
1944 –1949
9. Spinale FG: Myocardial matrix remodeling and the matrix
metalloproteinases: influence on cardiac form and function. Physiol
Rev 2007, 87:1285–1342
10. Wu H, Byrne MH, Stacey A, Goldring MB, Birkhead JR, Jaenisch R,
Krane SM: Generation of collagenase-resistant collagen by site-directed mutagenesis of murine pro alpha 1(I) collagen gene. Proc Natl
Acad Sci U S A 1990, 87:5888 –5892
11. Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch R: A targeted
mutation at the known collagenase cleavage site in mouse type I
collagen impairs tissue remodeling. J Cell Biol 1995, 130:227–237
12. Zhao W, Byrne MH, Boyce BF, Krane SM: Bone resorption induced by
parathyroid hormone is strikingly diminished in collagenase-resistant
mutant mice. J Clin Invest 1999, 103:517–524
13. Feng Q, Lu X, Jones DL, Shen J, Arnold JM: Increased inducible nitric
oxide synthase expression contributes to myocardial dysfunction and
higher mortality after myocardial infarction in mice. Circulation 2001,
104:700 –704
14. Gao XM, Dart AM, Dewar E, Jennings G, Du XJ: Serial echocardiographic assessment of left ventricular dimensions and function after
myocardial infarction in mice. Cardiovasc Res 2000, 45:330 –338
15. Subramanian SV, Kelm RJ, Polikandriotis JA, Orosz CG, Strauch AR:
Reprogramming of vascular smooth muscle alpha-actin gene expression as an early indicator of dysfunctional remodeling following heart
transplant. Cardiovasc Res 2002, 54:539 –548
16. Pickering JG, Weir L, Rosenfield K, Stetz J, Jekanowski J, Isner JM:
Smooth muscle cell outgrowth from human atherosclerotic plaque:
implications for the assessment of lesion biology. J Am Coll Cardiol
1992, 20:1430 –1439
17. Isner JM, Kearney M, Bauters C, Leclerc G, Pickering JG, Reissen R,
Weir L: Use of human tissue specimens obtained by directional
atherectomy to study restenosis. Trends Cardiovasc Med 1994,
4:213–221
18. Rocnik E, Saward L, Pickering JG: HSP47 expression by smooth
muscle cells is increased during arterial development and lesion
formation and is inhibited by fibrillar collagen. Arterioscler Thromb
Vasc Biol 2001, 21:40 – 46
19. Whittaker P, Kloner RA, Boughner DR, Pickering JG: Quantitative
assessment of myocardial collagen with picrosirius red staining and
circularly polarized light. Basic Res Cardiol 1994, 89:397– 410

2198
Nong et al
AJP November 2011, Vol. 179, No. 5

20. Pickering JG, Ford CM, Chow LH: Evidence for rapid accumulation
and persistently disordered architecture of fibrillar collagen in human
coronary restenosis lesions. Am J Cardiol 1996, 78:633– 637
21. Rocnik EF, Chan BMC, Pickering JG: Evidence for a role of collagen
synthesis in arterial smooth muscle cell migration. J Clin Invest 1998,
101:1889 –1898
22. Li S, Chow LH, Pickering JG: Cell surface-bound collagenase-1 and
focal substrate degradation stimulate the rear release of motile vascular smooth muscle cells. J Biol Chem 2000, 275:35384 –35392
23. Fera E, O’Neil C, Lee W, Li S, Pickering JG: Fibroblast growth factor-2
and remodeled type I collagen control membrane protrusion in human vascular smooth muscle cells: biphasic activation of Rac1. J Biol
Chem 2004, 279:35573–35582
24. Pickering JG, Boughner DR: Fibrosis in the transplanted heart and its
relation to donor ischemic time: assessment with polarized light microscopy and digital image analysis. Circulation 1990, 81:949 –958
25. Grinnell F: Fibroblasts, myofibroblasts, and wound contraction. J Cell
Biol 1994, 124:401– 404
26. Unemori EN, Werb Z: Reorganization of polymerized actin: a possible
trigger for induction of procollagenase in fibroblasts cultured in and
on collagen gels. J Cell Biol 1986, 103:1021–1031
27. Wilson EM, Moainie SL, Baskin JM, Lowry AS, Deschamps AM,
Mukherjee R, Guy TS, St John-Sutton MG, Gorman JH 3rd, Edmunds
LH Jr, Gorman RC, Spinale FG: Region- and type-specific induction
of matrix metalloproteinases in post-myocardial infarction remodeling. Circulation 2003, 107:2857–2863
28. Peterson JT, Li H, Dillon L, Bryant JW: Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression
in the infarcted rat. Cardiovasc Res 2000, 46:307–315
29. Fukumoto Y, Deguchi JO, Libby P, Rabkin-Aikawa E, Sakata Y, Chin
MT, Hill CC, Lawler PR, Varo N, Schoen FJ, Krane SM, Aikawa M:

30.

31.

32.

33.

34.

35.

36.

Genetically determined resistance to collagenase action augments
interstitial collagen accumulation in atherosclerotic plaques.
Circulation 2004, 110:1953–1959
Deguchi JO, Huang H, Libby P, Aikawa E, Whittaker P, Sylvan J, Lee
RT, Aikawa M: Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused
with angiotensin II. Lab Invest 2009, 89:315–326
Lindsey ML, Yoshioka J, MacGillivray C, Muangman S, Gannon J,
Verghese A, Aikawa M, Libby P, Krane SM, Lee RT: Effect of a
cleavage-resistant collagen mutation on left ventricular remodeling.
Circ Res 2003, 93:238 –245
Gao XM, Xu Q, Kiriazis H, Dart AM, Du XJ: Mouse model of postinfarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 2005,
65:469 – 477
Wang Q, Hummler E, Nussberger J, Clément S, Gabbiani G, Brunner
HR, Burnier M: Blood pressure, cardiac, and renal responses to salt
and deoxycorticosterone acetate in mice: role of Renin genes. J Am
Soc Nephrol 2002, 13:1509 –1516
Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks
WC: The activity of collagenase-1 is required for keratinocyte
migration on a type I collagen matrix. J Cell Biol 1997, 137:1445–
1457
Eckes B, Mauch C, Huppe G, Krieg T: Downregulation of collagen
synthesis in fibroblasts within three-dimensional collagen lattices involves transcriptional and posttranscriptional mechanisms. FEBS Lett
1993, 318:129 –133
van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L,
Narula J: Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 2010, 7:30 –37

